Oxford vaccine-trial chief sees ‘small chance’ of COVID-19 inoculations being ready by Christmas

The University of Oxford hopes to present late-stage trial results on its COVID-19 vaccine candidate, being developed with AstraZeneca, later this year
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.